LAHORE — The Pakistan Second-Hand Medical Equipment Importers Association has raised concerns regarding a recent policy notification by the Drug Regulatory Authority of Pakistan (DRAP). The association is urging the regulatory body to reassess the policy, which impacts the import of refurbished medical equipment, suggesting that a comprehensive consultation with industry stakeholders is necessary.
What Happened
On July 24, the Pakistan Second-Hand Medical Equipment Importers Association publicly expressed its reservations about DRAP’s new policy, as outlined in notification No. 1-1/2026/DD-MDMC. This notification governs the importation of refurbished medical devices into Pakistan. The association argues that the policy was formulated without adequate input from those directly affected by it, namely, the importers and distributors of second-hand medical equipment.
The association’s spokesperson stated, “We believe that the policy, as it stands, could significantly hinder the availability of affordable medical equipment in Pakistan, which is crucial for healthcare facilities operating on limited budgets.” The spokesperson emphasized the need for DRAP to engage in meaningful dialogue with stakeholders to ensure that the policy aligns with the realities of the market and the needs of the healthcare sector.
The notification specifies certain conditions and standards that refurbished medical equipment must meet to be eligible for import. However, importers claim that these standards are not only stringent but also fail to consider the practical challenges faced by the industry. They argue that the policy could lead to increased costs and reduced access to necessary medical equipment, particularly in rural and underserved areas.
Background
The importation of second-hand medical equipment has been a critical aspect of Pakistan’s healthcare system, particularly for smaller clinics and hospitals that cannot afford new equipment. Historically, refurbished equipment has provided a cost-effective solution, allowing these facilities to offer a broader range of services.
DRAP, established under the DRAP Act of 2012, is responsible for ensuring the quality and safety of drugs and medical devices in Pakistan. Over the years, the authority has implemented various policies aimed at regulating the import and distribution of medical equipment to ensure compliance with international standards.
Previous policies have also faced criticism from industry stakeholders, who argue that overly stringent regulations can stifle innovation and accessibility. The current notification is seen as part of DRAP’s ongoing efforts to enhance regulatory oversight, albeit with unintended consequences for the industry.
Why It Matters
The implications of this policy are significant for Pakistan’s healthcare sector. Access to affordable medical equipment is crucial for improving healthcare outcomes, particularly in rural and low-income areas where resources are limited. By potentially restricting the import of refurbished equipment, the policy could exacerbate existing disparities in healthcare access.
Economically, the policy could impact small and medium-sized enterprises involved in the import and distribution of medical equipment. These businesses play a vital role in the supply chain, and any disruption could lead to job losses and reduced economic activity.
Moreover, the policy could have broader implications for Pakistan’s healthcare system, which is already under pressure due to population growth and increasing demand for services. Without affordable equipment, healthcare providers may struggle to expand their services, ultimately affecting patient care and outcomes.
Internationally, the policy could affect Pakistan’s trade relations with countries that export refurbished medical equipment. It is essential for DRAP to balance regulatory oversight with the need to maintain open trade channels and ensure the availability of essential medical devices.
Key Takeaways
- The Pakistan Second-Hand Medical Equipment Importers Association has urged DRAP to review its new import policy.
- The policy, as per notification No. 1-1/2026/DD-MDMC, affects the import of refurbished medical equipment.
- Importers argue that the policy could limit access to affordable medical devices, impacting healthcare services.
- DRAP aims to ensure quality and safety but faces criticism for potentially hindering market access.
- The policy’s economic and healthcare implications could affect both domestic and international stakeholders.
Source Attribution
This article is based on official government statements, press releases, and public communications from relevant authorities.
